Effects of environmental carcinogen benzo(a)pyrene on canine adipose-derived mesenchymal stem cells

Research in Veterinary Science

Volumn 103, Issue , 2015, Pages 34-43

  Rathore, Kusum ^a   Cekanova, Maria ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Adipogenesis; AhR signaling pathway; Benzo(a)pyrene; Canine; Environmental carcinogenesis; Mesenchymal stem cell

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; CARCINOGEN; CYTOCHROME P450 1A1; ENVIRONMENTAL CHEMICAL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLLUTANT;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CELL; CELL DIFFERENTIATION; CELL ISOLATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DOG BREED; DOWN REGULATION; FEMALE; INTRACELLULAR TRANSPORT; MESENCHYMAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; ANIMAL; DOG; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; POLLUTANT; TOXICITY;

ANIMALS; BENZO(A)PYRENE; CARCINOGENS, ENVIRONMENTAL; CELL DIFFERENTIATION; CELL PROLIFERATION; DOGS; ENVIRONMENTAL POLLUTANTS; GENE EXPRESSION REGULATION; MESENCHYMAL STROMAL CELLS; PPAR GAMMA; RECEPTORS, ARYL HYDROCARBON;

EID: 84949568108     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2015.09.012     Document Type: Article

References (57)

1. Alexander D.L., Ganem L.G., Fernandez-Salguero P., Gonzalez F., Jefcoate C.R. Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis. J. Cell Sci. 1998, 111:3311-3322.
2. Backer L.C., Grindem C.B., Corbett W.T., Cullins L., Hunter J.L. Pet dogs as sentinels for environmental contamination. Sci. Total Environ. 2001, 274:161-169.
3. Bidgoli S.A., Eftekhari T. Role of exogenous and endogenous sources of estrogen on the incidence of breast fibroadenoma: case-control study in Iran. Asian Pac. J. Cancer Prev. 2011, 12:1289-1293.
4. Breast Cancer Facts and Figure (accessed November 13th 2013). http://www.cancer.org/acs/groups/content/research/documents/document/acspc-040951.pdf.
5. Cekanova M., Lee S.-H., McEntee M.F., Baek S.J. MCC-555-induced NAG-1 expression is mediated in part by KLF4. Eur. J. Pharmacol. 2010, 637:30-37.
6. Cekanova M., Masi T., Plummer H.K., Majidi M., Fedorocko P., Schuller H.M. Pulmonary fibroblasts stimulate the proliferation of cell lines from human lung adenocarcinomas. Anticancer Drugs 2006, 17:771-781.
7. Cekanova M., Uddin M.J., Bartges J.W., Callens A., Legendre A.M., Rathore K., Wright L., Carter A., Marnett L.J. Molecular imaging of cyclooxygenase-2 in canine transitional cell carcinomas in vitro and in vivo. Cancer Prevention Research 2013, 6:466-476.
8. Cekanova M., Yuan J.S., Li X., Kim K., Baek S.J. Gene alterations by peroxisome proliferator-activated receptor γ agonists in human colorectal cancer cells. Int. J. Oncol. 2008, 32:809-819.
9. Ciganek M., Neca J., Adamec V., Janosek J., Machala M. A combined chemical and bioassay analysis of traffic-emitted polycyclic aromatic hydrocarbons. Sci. Total Environ. 2004, 334-335:141-148.
10. Coleman R.E., Rubens R.D. The clinical course of bone metastases from breast cancer. Br. J. Cancer 1987, 55:61-66.
11. Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 2003, 43:309-334.
12. Dorn C.R. The epidemiology of cancer in animals. Calif. Med. 1967, 107:481-489.
13. Farmer S.R. Regulation of PPARγ activity during adipogenesis. Int. J. Obes. (Lond) 2005, 29(Suppl 1):S13-S16.
14. Fujii-Kuriyama Y., Mimura J. Molecular mechanisms of AhR functions in the regulation of cytochrome P450 genes. Biochem. Biophys. Res. Commun. 2005, 338:311-317.
15. Gangadhara S., Barrett-Lee P., Nicholson R.I., Hiscox S. Pro-metastatic tumor-stroma interactions in breast cancer. Future Oncol. 2012, 8:1427-1442.
16. Glickman L.T., Domanski L.M., Maguire T.G., Dubielzig R.R., Churg A. Mesothelioma in pet dogs associated with exposure of their owners to asbestos. Environ. Res. 1983, 32:305-313.
17. Gregoire F.M., Smas C.M., Sul H.S. Understanding adipocyte differentiation. Physiol. Rev. 1998, 78:783-809.
18. Grisendi G., Bussolari R., Veronesi E., Piccinno S., Burns J.S., De Santis G., Loschi P., Pignatti M., Di Benedetto F., Ballarin R., Di Gregorio C., Guarneri V., Piccinini L., Horwitz E.M., Paolucci P., Conte P., Dominici M. Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers. American Journal of Cancer Research 2011, 1:787-805.
19. Hayes H.M., Hoover R., Tarone R.E. Bladder cancer in pet dogs: a sentinel for environmental cancer?. Am. J. Epidemiol. 1981, 114:229-233.
20. Hoar S.K., Blair A., Holmes F.F., Boysen C.D., Robel R.J., Hoover R., Fraumeni J.F. Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA 1986, 256:1141-1147.
21. Kang, S.C., Lee, B.M., 2005. Effect of estrogen receptor (ER) on benzo[a]pyrene-DNA adduct formation in human breast cancer cells. Journal of Toxicology and Environmental Health. Part A 68, 1833-1840.
22. Karnoub A.E., Dash A.B., Vo A.P., Sullivan A., Brooks M.W., Bell G.W., Richardson A.L., Polyak K., Tubo R., Weinberg R.A. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007, 449:557-563.
23. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. The Journal of Clinical Endocrinology & Metabolism 2004, 89:2548-2556.
24. Knapp D.W., Waters D.J. Naturally occurring cancer in pet dogs: important models for developing improved cancer therapy for humans. Mol. Med. Today 1997, 3:8-11.
25. Lee B.M., Shim G.A. Dietary exposure estimation of benzo [a] pyrene and cancer risk assessment. J. Toxic. Environ. Health A 2007, 70:1391-1394.
26. Lerner S.P., Schoenberg M.P., Sternberg C.N. Textbook of Bladder Cancer 2006, Taylor and Francis.
27. Lijinsky W. The formation and occurrence of polynuclear aromatic hydrocarbons associated with food. Mutat. Res. 1991, 259:251-261.
28. Liu M., Xu J., Deng H. Tangled fibroblasts in tumor-stroma interactions. Int. J. Cancer 2011.
29. Ma Q., Baldwin K.T. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway Role of the transcription activation and DNA binding of AhR. J. Biol. Chem. 2000, 275:8432-8438.
30. MacEwen E.G. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Rev. 1990, 9:125-136.
31. Macon M.B., Fenton S.E. Endocrine disruptors and the breast: early life effects and later life disease. J. Mammary Gland Biol. Neoplasia 2013, 18:43-61.
32. Owen L.N. A comparative study of canine and human breast cancer. Invest. Cell Pathol. 1979, 2:257-275.
33. Paoloni M., Khanna C. Translation of new cancer treatments from pet dogs to humans. Nat. Rev. Cancer 2008, 8:147-156.
34. Paunescu V., Bojin F.M., Tatu C.A., Gavriliuc O.I., Rosca A., Gruia A.T., Tanasie G., Bunu C., Crisnic D., Gherghiceanu M., Tatu F.R., Tatu C.S., Vermesan S. Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences. J. Cell. Mol. Med. 2011, 15:635-646.
35. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
36. Podechard N., Fardel O., Corolleur M., Bernard M., Lecureur V. Inhibition of human mesenchymal stem cell-derived adipogenesis by the environmental contaminant benzo(a)pyrene. Toxicol. In Vitro 2009, 23:1139-1144.
37. Rathore K., Choudhary S., Odoi A., Wang H.C. Green tea catechin intervention of reactive oxygen species-mediated ERK pathway activation and chronically induced breast cell carcinogenesis. Carcinogenesis 2012, 33:174-183.
38. Reif J.S., Dunn K., Ogilvie G.K., Harris C.K. Passive smoking and canine lung cancer risk. Am. J. Epidemiol. 1992, 135:234-239.
39. Rosen E.D., Spiegelman B.M. Molecular regulation of adipogenesis. Annual Review of Cell and Developmental Biology 2000, 145-171.
40. Scherer G., Frank S., Riedel K., Meger-Kossien I., Renner T. Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons. Cancer Epidemiol. Biomarkers Prev. 2000, 9:373-380.
41. Shimba S., Todoroki K., Aoyagi T., Tezuka M. Depletion of arylhydrocarbon receptor during adipose differentiation in 3T3-L1 cells. Biochem. Biophys. Res. Commun. 1998, 249:131-137.
42. Shimba S., Wada T., Tezuka M. Arylhydrocarbon receptor (AhR) is involved in negative regulation of adipose differentiation in 3T3-L1 cells AhR inhibits adipose differentiation independently of dioxin. J. Cell Sci. 2001, 114:2809-2817.
43. Sinha R., Kulldorff M., Gunter M.J., Strickland P., Rothman N. Dietary benzo [a] pyrene intake and risk of colorectal adenoma. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2030-2034.
44. Siriwardhana N., Kalupahana N.S., Cekanova M., LeMieux M., Greer B., Moustaid-Moussa N. Modulation of adipose tissue inflammation by bioactive food compounds. J. Nutr. Biochem. 2013, 24:613-623.
45. Stolpmann K., Brinkmann J., Salzmann S., Genkinger D., Fritsche E., Hutzler C., Wajant H., Luch A., Henkler F. Activation of the aryl hydrocarbon receptor sensitises human keratinocytes for CD95L- and TRAIL-induced apoptosis. Cell Death & Disease 2012, 3.
46. Swanson H.I., Perdew G.H. Half-life of aryl hydrocarbon receptor in Hepa 1 cells: evidence for ligand-dependent alterations in cytosolic receptor levels. Arch. Biochem. Biophys. 1993, 302:167-174.
47. Swartz M.A., Iida N., Roberts E.W., Sangaletti S., Wong M.H., Yull F.E., Coussens L.M., DeClerck Y.A. Tumor microenvironment complexity: emerging roles in cancer therapy. Cancer Res. 2012, 72:2473-2480.
48. Tedder T.F., Isaacs C.M. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily. Journal of Immunology 1989, 143:712-717.
49. Ueng T.H., Wang H.W., Huang Y.P., Hung C.C. Antiestrogenic effects of motorcycle exhaust particulate in MCF-7 human breast cancer cells and immature female rats. Arch. Environ. Contam. Toxicol. 2004, 46:454-462.
50. van Grevenynghe J., Bernard M., Langouet S., Le Berre C., Fest T., Fardel O. Human CD34-positive hematopoietic stem cells constitute targets for carcinogenic polycyclic aromatic hydrocarbons. J. Pharmacol. Exp. Ther. 2005, 314:693-702.
51. van Grevenynghe J., Monteiro P., Gilot D., Fest T., Fardel O. Human endothelial progenitors constitute targets for environmental atherogenic polycyclic aromatic hydrocarbons. Biochem. Biophys. Res. Commun. 2006, 341:763-769.
52. Vaziri C., Schneider A., Sherr D.H., Faller D.V. Expression of the aryl hydrocarbon receptor is regulated by serum and mitogenic growth factors in murine 3T3 fibroblasts. J. Biol. Chem. 1996, 271:25921-25927.
53. Wang D., Gao H., Bandyopadhyay A., Wu A., Yeh I.T., Chen Y., Zou Y., Huang C., Walter C.A., Dong Q., Sun L.Z. Pubertal bisphenol A exposure alters murine mammary stem cell (MaSC) function leading to early neoplasia in regenerated glands. Cancer Prev. Res. (Phila.) 2014, 7:445-455.
54. Wang T., Xu J., Yu X., Yang R., Han Z.C. Peroxisome proliferator-activated receptor γ in malignant diseases. Crit. Rev. Oncol. Hematol. 2006, 58:1-14.
55. Weigelt B., Bissell M.J. Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Semin. Cancer Biol. 2008, 18:311-321.
56. Whitlock J.P. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 1999, 39:103-125.
57. Yoshioka W., Peterson R.E., Tohyama C. Molecular targets that link dioxin exposure to toxicity phenotypes. J. Steroid Biochem. Mol. Biol. 2011, 127:96-101.